Northwestern Mutual Wealth Management
INO icon

Northwestern Mutual Wealth Management’s Inovio Pharmaceuticals INO Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1
Closed -$2 – 4129
2025
Q3 		$2 Sell
1
-37
-97% -$71 ﹤0.01% 3786
2025
Q2 		$77 Buy
+38
New +$73 ﹤0.01% 3565
2025
Q1 		– Sell
-193
Closed -$353 – 3803
2024
Q4 		$353 Buy
193
+191
+9,550% +$845 ﹤0.01% 3411
2024
Q3 		$12 Buy
+2
New +$16 ﹤0.01% 3561
2024
Q2 		– Sell
-30
Closed -$416 – 3652
2024
Q1 		$416 Buy
30
+24
+400% +$207 ﹤0.01% 3326
2023
Q4 		$36 Buy
+6
New +$30 ﹤0.01% 3414
2023
Q1 		– Sell
-3
Closed -$55 – 3482
2022
Q4 		$55 Sell
3
-775
-100% -$17.6K ﹤0.01% 3246
2022
Q3 		$16K Sell
778
-97
-11% -$2.48K ﹤0.01% 2304
2022
Q2 		$18K Buy
875
+100
+13% +$2.82K ﹤0.01% 2296
2022
Q1 		$33K Sell
775
-17
-2% -$766 ﹤0.01% 2108
2021
Q4 		$47K Buy
792
+17
+2% +$1.36K ﹤0.01% 2002
2021
Q3 		$67K Hold
775
– – ﹤0.01% 1791
2021
Q2 		$86K Hold
775
– – ﹤0.01% 1658
2021
Q1 		$86K Hold
775
– – ﹤0.01% 1545
2020
Q4 		$82K Hold
775
– – ﹤0.01% 1469
2020
Q3 		$108K Sell
775
-83
-10% -$17.3K ﹤0.01% 1249
2020
Q2 		$278K Buy
858
+4
+0.5% +$642 ﹤0.01% 862
2020
Q1 		$76K Buy
854
+79
+10% +$4.87K ﹤0.01% 1212
2019
Q4 		$31K Hold
775
– – ﹤0.01% 1608
2019
Q3 		$19K Hold
775
– – ﹤0.01% 1748
2019
Q2 		$27K Hold
775
– – ﹤0.01% 1607
2019
Q1 		$35K Hold
775
– – ﹤0.01% 1511
2018
Q4 		$37K Hold
775
– – ﹤0.01% 1360
2018
Q3 		$52K Sell
775
-1,042
-57% -$58K ﹤0.01% 1304
2018
Q2 		$85K Hold
1,817
– – ﹤0.01% 1049
2018
Q1 		$103K Hold
1,817
– – ﹤0.01% 948
2017
Q4 		$90K Hold
1,817
– – ﹤0.01% 956
2017
Q3 		$138K Hold
1,817
– – ﹤0.01% 805
2017
Q2 		$171K Buy
+1,817
New +$155K ﹤0.01% 720

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northwestern Mutual Wealth Management's INO Position: Q4 2025 in Review

Northwestern Mutual Wealth Management sold out of Inovio Pharmaceuticals (INO) in Q4 2025, closing a stake of 1 share — an estimated $2 sold.

Northwestern Mutual Wealth Management first reported a position in INO in Q2 2017 and held it in 29 quarters. The position peaked at $278K in Q2 2020. 102 funds tracked by Wall St. Rank hold INO as of Q4 2025.

  • Northwestern Mutual Wealth Management reported no remaining Inovio Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 1 Inovio Pharmaceuticals share in Q4 2025, an estimated $2.
  • Northwestern Mutual Wealth Management first reported a position in Inovio Pharmaceuticals in Q2 2017 and held it in 29 quarters.
  • Northwestern Mutual Wealth Management's Inovio Pharmaceuticals position peaked at $278K in Q2 2020.
  • 102 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2025.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2025, filed 5 Feb 2026.